Brenda B. Cirincione
Brenda B. Cirincione publishes mostly in Endocrinology, Diabetes and Metabolism, Pharmacology and Cardiology and Cardiovascular Medicine, on topics such as Antibiotics Pharmacokinetics and Efficacy, Diabetes Treatment and Management and Antibiotic Resistance in Bacteria.
- World rank
- #1,876,662 of 7,710,434 ranked researchers
- Rank in United States
- #574,115 of 1,627,098
- Works
- 36
- Citations
- 1.4k
- Citations per work
- 37.8
What does Brenda B. Cirincione research?
Brenda B. Cirincione's work is mostly in Medicine (44%), Biochemistry, Genetics and Molecular Biology (13%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1643.8%
- Health Sciences1643.6%
- Medicine1643.6%
- Life Sciences512.6%
- 1Endocrinology, Diabetes and Metabolism16% of their works
- 2Pharmacology13% of their works
- 3Cardiology and Cardiovascular Medicine10% of their works
- 4Molecular Biology7% of their works
- 5Molecular Medicine6% of their works
- 6Epidemiology6% of their works
Research topics
- Antibiotics Pharmacokinetics and Efficacy
- Diabetes Treatment and Management
- Antibiotic Resistance in Bacteria
- Diabetes Management and Research
- Antimicrobial Resistance in Staphylococcus
- Bacterial Identification and Susceptibility Testing
- Receptor Mechanisms and Signaling
- Cardiac electrophysiology and arrhythmias
Which keywords describe Brenda B. Cirincione's research?
The keywords of their largest research topics: Antimicrobial Resistance, Glycemic Control, Insulin Therapy, Antibiotic Pharmacokinetics, Critically Ill Patients, Cardiovascular Outcomes, Type 2 Diabetes and Antibiotic Resistance.
- Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry
- G-Protein-Coupled Receptors
- Arrhythmias
- MRSA
- Diabetes
- Antibiotic Resistance
- Cardiovascular Outcomes
- Antibiotic Pharmacokinetics
- Glycemic Control
- Antimicrobial Resistance
- Insulin Therapy
- Critically Ill Patients
- Type 2 Diabetes
- Multidrug-Resistant Bacteria
- Hypoglycemia
- Staphylococcus aureus
- Crystal Structure
- Long-QT Syndrome
- Microorganism Identification
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Antimicrobial Resistance162 topics
- Glycemic Control142 topics
- Insulin Therapy142 topics
- Antibiotic Pharmacokinetics121 topic
- Critically Ill Patients121 topic
- Cardiovascular Outcomes101 topic
- Type 2 Diabetes101 topic
- Antibiotic Resistance61 topic
- Multidrug-Resistant Bacteria61 topic
- Diabetes41 topic
- Hypoglycemia41 topic
- MRSA41 topic
- Staphylococcus aureus41 topic
- Arrhythmias31 topic
- Crystal Structure31 topic
- G-Protein-Coupled Receptors31 topic
- Long-QT Syndrome31 topic
- Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry31 topic
- Microorganism Identification31 topic
Where does Brenda B. Cirincione work?
Brenda B. Cirincione's main affiliation in the publication record is Cognizant (United States), United States.
How many publications and citations does Brenda B. Cirincione have?
OpenAlex counts 36 works and 1,359 citations for Brenda B. Cirincione, an h-index of 19, ranking #1,876,662 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Brenda B. Cirincione. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.